RS Crum Inc’s Eli Lilly LLY Stock Holding History

RS Crum Inc’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$393K	Sell	427 -6	-1%	-$6.08K	0.08%	73
2025 Q4	$465K	Hold	433	–	–	0.09%	62
2025 Q3	$330K	Sell	433 -4	-0.9%	-$2.98K	0.07%	79
2025 Q2	$341K	Sell	437 -21	-5%	-$16.3K	0.08%	71
2025 Q1	$378K	Buy	458 +49	+12%	+$40.8K	0.1%	64
2024 Q4	$316K	Buy	409 +2	+0.5%	+$1.66K	0.08%	74
2024 Q3	$360K	Buy	407 +93	+30%	+$83.6K	0.08%	71
2024 Q2	$284K	Buy	+314	New	+$251K	0.07%	76

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RS Crum Inc's LLY Position: Q1 2026 in Review

RS Crum Inc reduced its Eli Lilly (LLY) stake by 1.4% in Q1 2026, selling an estimated $6.08K and leaving 427 shares worth $393K. The position accounts for 0.08% of the portfolio, ranked #73.

RS Crum Inc first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $465K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

RS Crum Inc held 427 shares of Eli Lilly worth $393K as of Q1 2026.
RS Crum Inc sold 6 Eli Lilly shares in Q1 2026, an estimated $6.08K.
Eli Lilly made up 0.08% of RS Crum Inc's portfolio in Q1 2026, its #73 holding.
RS Crum Inc first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
RS Crum Inc's Eli Lilly position peaked at $465K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on RS Crum Inc's 13F filing for Q1 2026, filed 15 Apr 2026.